These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35073922)

  • 1. Decoquinate liposomes: highly effective clearance of Plasmodium parasites causing severe malaria.
    Zeng S; Wang H; Tao L; Ning X; Fan Y; Zhao S; Qin L; Chen X
    Malar J; 2022 Jan; 21(1):24. PubMed ID: 35073922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved efficacy of doxycycline in liposomes against Plasmodium falciparum in culture and Plasmodium berghei infection in mice.
    Rajendran V; Singh C; Ghosh PC
    Can J Physiol Pharmacol; 2018 Nov; 96(11):1145-1152. PubMed ID: 30075085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria.
    Rajendran V; Rohra S; Raza M; Hasan GM; Dutt S; Ghosh PC
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1304-18. PubMed ID: 26666937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of Decoquinate Solid Dispersion by Hot-Melt Extrusion as an Oral Dosage Form Targeting Liver-Stage
    Wang H; Fan Y; Qin L; Cheng Z; Chen X; Zeng S; Liang S; Tong Y; Tao Z; Liu Y; Liu X; Ning X; Chen P; Zhao S; Chen X
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0221821. PubMed ID: 35658489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Straightforward conversion of decoquinate into inexpensive tractable new derivatives with significant antimalarial activities.
    Beteck RM; Coertzen D; Smit FJ; Birkholtz LM; Haynes RK; N'Da DD
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3006-3009. PubMed ID: 27210430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplasmodial efficacy of
    Satish PVV; Kumari DS; Sunita K
    J Vector Borne Dis; 2017; 54(3):215-225. PubMed ID: 29097636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA).
    Satish PVV; Sunita K
    BMC Complement Altern Med; 2017 Sep; 17(1):458. PubMed ID: 28893216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage Plasmodium infections in mice.
    Wang H; Li Q; Reyes S; Zhang J; Zeng Q; Zhang P; Xie L; Lee PJ; Roncal N; Melendez V; Hickman M; Kozar MP
    Nanomedicine; 2014 Jan; 10(1):57-65. PubMed ID: 23891618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
    Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor.
    Nam TG; McNamara CW; Bopp S; Dharia NV; Meister S; Bonamy GM; Plouffe DM; Kato N; McCormack S; Bursulaya B; Ke H; Vaidya AB; Schultz PG; Winzeler EA
    ACS Chem Biol; 2011 Nov; 6(11):1214-22. PubMed ID: 21866942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Hydroxy-propanamidines, a New Class of Orally Active Antimalarials Targeting Plasmodium falciparum.
    Knaab TC; Held J; Burckhardt BB; Rubiano K; Okombo J; Yeo T; Mok S; Uhlemann AC; Lungerich B; Fischli C; Pessanha de Carvalho L; Mordmüller B; Wittlin S; Fidock DA; Kurz T
    J Med Chem; 2021 Mar; 64(6):3035-3047. PubMed ID: 33666415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B
    J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eugenol disrupts Plasmodium falciparum intracellular development during the erythrocytic cycle and protects against cerebral malaria.
    Pontes KAO; Silva LS; Santos EC; Pinheiro AS; Teixeira DE; Peruchetti DB; Silva-Aguiar RP; Wendt CHC; Miranda KR; Coelho-de-Souza AN; Leal-Cardoso JH; Caruso-Neves C; Pinheiro AAS
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129813. PubMed ID: 33321150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
    Shmuklarsky MJ; Klayman DL; Milhous WK; Kyle DE; Rossan RN; Ager AL; Tang DB; Heiffer MH; Canfield CJ; Schuster BG
    Am J Trop Med Hyg; 1993 Mar; 48(3):377-84. PubMed ID: 8470775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.